Telomir Pharmaceuticals Statistics
NASDAQ: TELOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.13+0.01 (+0.89%)
Market open · Delayed 15 min · as of Oct 8, 10:50 AM ET
Telomir Pharmaceuticals by the numbers
Telomir Pharmaceuticals has a market capitalization of $83.2 million based on 73.62M shares outstanding. With trailing EPS of $-1.11, Telomir Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 3.2% below its 50-day average and 9.8% below its 200-day average.
Average daily trading volume is 97.37K shares, or about $110,026 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
TELO valuation vs. peer median
| Metric | TELO | Peer median | Difference |
|---|---|---|---|
| Market cap | $83.19M | $80.28M | +4% |
| Avg. volume | 97.37K | 201.63K | -52% |
Peer median across 8 companies: PMN, EQ, OKUR, ACRV, INCR, MIST, RFL, NTHI.
Valuation
- Market cap
- $83.19M
- EPS (TTM)
- $-1.11
- Shares outstanding
- 73.62M
Price and trading
- Previous close
- 1.12
- Open
- 1.11
- Day range
- 1.10 – 1.14
- 52-week range
- 0.888 – 2.09
- 52-week change
- -37.78%
- Beta
- —
- Volume
- 44.72K
- Average volume
- 97.37K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 11, 2025
Additional statistics
- Market Cap
- 83.19M
- Forward Pe
- -4.04
- Eps
- -1.11
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 2.09
- Week52 Low
- 0.89
- Avg Volume
- 97,368.00
- Shares Outstanding
- 73.62M
- Ma50
- 1.17
- Ma200
- 1.25
- Earnings Date
- Aug 11, 2025
- Pct From52w High
- -45.96%
- Pct From52w Low
- 27.25%